Cuadro médico

Dr. Pedro Bilbao ZulaicaOncología

Nº de colegiado: 484802619
Dr. Pedro Bilbao Zulaica
Cuadro médico
>
Dr. Pedro Bilbao Zulaica

Titulaciones

  • Licenciatura en la Universidad de Valladolid (1967-1973).
  • Doctorado en la Universidad del País Vasco (1974-1978).

Experiencia profesional

  • MIR: Hospital de Cruces, Vizcaya (1974-1977).
  • Médico Adjunto en Oncología Radioterápica: Hospital Nª Sª de Aránzazu-San Sebastián (1979-1982).
  • Jefe de Sección de Oncología Radioterápica. Hospital de Txagorritxu, Vitoria (1983-1998).
  • Jefe de Servicio de Oncología Radioterápica. Hospital de Cruces, Vizcaya (desde 1999-hasta la actualidad).

Experiencia docente

  • Catedratico en la U.D. Fac. Medicina y Odontologia. Dpto. Cirugia, Radiologia y Medicina Física. UPV/EHU Hospital Universitario Cruces

Publicaciones

  • Pattern of Relapse after Metastases Directed Therapy in Patients with Oligorecurrent Prostate Cancer Detected with Choline PET-CT.
    P. Bilbao,I. San Miguel, D. Büchser, F. Suarez, F. Casquero, I. Fernandez, E. Rodeño, R. Ortiz de Zarate, R. Llarena...
    November 1, 2018Volume 102, Issue 3, Supplement, Page S164.
    www.redjournal.org
  • Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?.
    J Cacicedo, A Gómez Iturriaga, Alejandro Maleta, Francisco Casquero, Pedro Bilbao.
    Volume62, Issue4, August 2018, Pages 578-584.
    onlinelibrary.wiley.com
  • Late Toxicity after Single Dose HDR Prostate Brachytherapy and EBRT for Localized Prostate Cancer: Clinical and Dosimetric Predictors in a Prospective Cohort Study.
    David Büchser, A Gómez Iturriaga, A Navarro, V Morillo, P Willisch, JL Lopez Guerra, A Illescas, F Casquero, O Del Hoyo, R Ciervide, L Martinez Indart, P. Bilbao...
    July–August, 2018 Volume 17, Issue 4, Supplement, Page S74.
    www.brachyjournal.com
  • Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer.
    Alfonso Gomez Iturriaga, Francisco Casquero, Jose Ignacio Pijoan, Juanita Crook, Pedro Bilbao.
    August 1, 2018Volume 101, Issue 5, Pages 1172–1178.
    www.redjournal.org
  • EP-1612: Pre-treatment mpMRI accuracy and prognostic value in intermediate risk localized prostate cancer.
    D. Büchser, A. Gómez-Iturriaga, F. Casquero, A. Urresola, A. Ezquerro, J. Cacicedo, I. San Miguel, F. Suarez, P. Bilbao.
    April 2018Volume 127, Supplement 1, Pages S867–S868.
    www.thegreenjournal.com
  • Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    J. Cacicedo, Fernandez, O. del Hoyo, A. Navarro, A. Gomez-Iturriaga, J. Ignacio Pijoan P. Bilbao.
    November 2017, Volume 19, Issue 11, pp 1337–1349.
    link.springer.com
  • Transperineal biopsies of MRI-detected aggressive index lesions in low- and intermediate-risk prostate cancer patients: Implications for treatment decision.
    A. Gomez-Iturriaga, F. Casquero, J.I. Lopez, A. Urresola, A. Ezquerro, D. Buscher, P. Bilbao, J. Crook.
    January–February, 2017. Volume 16, Issue 1, Pages 201–206. Brachytherapy. DOI: https://doi.org/10.1016/j.brachy.2016.11.004
    www.brachyjournal.com
  • Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.
    David Buchser, Alfonso Gomez-Iturriaga, J. Ignacio Rodriguez Melcon, Francisco Casquero, Roberto Llarena, Jon Cacicedo, Pedro Bilbao.
    J Contemp Brachytherapy 2016; 8, 6: 477–483, Journal of Contemporary Brachytherapy. DOI: https://doi.org/10.5114/jcb.2016.64441.
    www.termedia.pl
  • Outcomes After a First and/or Second Salvage Treatment in Patients With Oligometastatic Prostate Cancer Recurrence Detected by (18-F) Choline Positron Emission Tomography/Computed Tomography.
    A. Gomez-Iturriaga, F. Casquero, I. Fernandez, E. Rodeño, A. Urresola, A. Ezquerro, R. Llarena, J. Cacicedo, A. Ahtamon, P. Bilbao.
    October 1, 2016, Volume 96, Issue 2, Supplement, Page E250. Radiation Oncology. DOI: https://doi.org/10.1016/j.ijrobp.2016.06.1250
    www.redjournal.org
  • Salvage Treatment in Patients With Prostate Cancer Oligorecurrence: Impact of 18-F-Fluorocholine Positron Emission Tomography/Computed Tomography on Clinical Decision Making.
    A. Olarte, A. Gomez-Iturriaga, I. Fernandez, F. Casquero, J. Cacicedo, A. Urresola, A. Ezquerro, R. Llarena, P. Bilbao, E. Rodeño.
    October 1, 2016Volume 96, Issue 2, Supplement, Pages E224–E225. Radiation Oncology. DOI: https://doi.org/10.1016/j.ijrobp.2016.06.1153
    www.redjournal.org
  • Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
    Jon Cacicedo, Arturo Navarro, Olga del Hoyo, Alfonso Gomez-Iturriaga, Pedro Bilbao...
    August 02, 2016. Volume 89, Issue 1067 . DOI: https://doi.org/10.1259/bjr.20160217
    www.birpublications.org
  • Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial.
    Alfonso Gomez-Iturriaga, Francisco Casquero, Arantza Urresola, Ana Ezquerro, Jose I. Lopez, Pedro Bilbao...
    April 2016, Volume 119, Issue 1, Pages 91–96, Radiotherapy & Oncology. DOI: https://doi.org/10.1016/j.radonc.2016.02.004
    www.thegreenjournal.com
  • OC-0089: Phase II trial of dose escalation to dominant intraprostatic lesion with TRUS-MRI guided real time HDR brachytherapy.
    Alfonso Gomez-Iturriaga, Francisco Casquero, Arantza Urresola, Ana Ezquerro, Jose I. Lopez, Pedro Bilbao...
    April 2015, Volume 115, Supplement 1, Page S45, Radiotherapy & Oncology. DOI: https://doi.org/10.1016/S0167-8140(15)40089-1
    www.thegreenjournal.com
  • Stereotactic body radiotherapy: An attractive treatment modality for recurrent head and neck carcinoma. (Regarding Lartigau et al.: Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer).
    Jon Cacicedo, Pedro Bilbao
    June 2014, Volume 111, Issue 3, Pages 482–483, Radiotherapy & Oncology. DOI: https://doi.org/10.1016/j.radonc.2014.01.028
    www.thegreenjournal.com
  • Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
    Jon Cacicedo, Iratxe Fernandez, Olga del Hoyo, Pedro Bilbao...
    August 2015, Volume 42, Issue 9, pp 1378–1389, Semantic Scholar. DOI: 10.1007/s00259-015-3071-0
    link.springer.com
  • A prospective analysis of inter- and intrafractional errors to calculate CTV to PTV margins in head and neck patients.
    J. F. Perez, R. Ortiz de Zarate, O. del Hoyo, F. Casquero, A. Gómez-Iturriaga, A. Lasso, E. Boveda, P. Bilbao
    February 2015, Volume 17, Issue 2, pp 113–120, Semantic Scholar. DOI: 10.1007/s12094-014-1200-z
    link.springer.com
  • Is argon plasma coagulation an effective and safe treatment option for patients with chronic radiation proctitis after high doses of radiotherapy?.
    Eduardo Hortelano, Alfonso Gómez-Iturriaga, Roberto Ortiz-de-Zárate, Manuel Zaballa, Pedro Bilbao.
    Rev Esp Enferm Dig (Madrid), Vol. 106, N.º 3, pp. 165-170, 2014. 1130-0108/2014/106/3/165-170. Revista Española de Enfermedades Digestivas. Copyright © 2014 Arán Ediciones, S. L
    www.grupoaran.com
  • Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy.
    Alfonso Gomez-Iturriaga, Juanita Crook, Francisco Casquero, Claudia Carvajal, Arantxa Urresola, Pedro Bilbao...
    J Contemp Brachytherapy. 2014 Jun; 6(2): 154–160. Published online 2014 Jun 9. doi: 10.5114/jcb.2014.43299
    www.ncbi.nlm.nih.gov
  • Undergraduate cancer education in Spain: The debate, the opportunities and the initiatives of the University Forum of the Spanish Society of Radiation Oncology (SEOR).
    Pedro Lara, Felipe A. Calvo, Ferran Guedea, Pedro Bilbao, Alberto Biete.
    Rep Pract Oncol Radiother. 2013 Nov; 18(6): 405–413. Published online 2013 Nov 9. doi: 10.1016/j.rpor.2013.09.003
    www.ncbi.nlm.nih.gov
  • A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy.
    Jon Cacicedo, Francisco Casquero, Lorea Martinez-Indart, Olga del Hoyo, Alfonso Gomez de Iturriaga, Arturo Navarro, Pedro Bilbao.
    Chin J Cancer. 2014 Apr; 33(4): 204–210. doi: 10.5732/cjc.013.10009
    www.ncbi.nlm.nih.gov
  • The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach.
    Jon Cacicedo, Francisco Casquero, Filippo Alongi, Olga del Hoyo, Alfonso Gomez de Iturriaga, Arturo Navarro, Pedro Bilbao.
    February 2014, Volume 40, Issue 1, Pages 178–189 Cancer treatment Reviews. DOI: https://doi.org/10.1016/j.ctrv.2013.08.002
    www.cancertreatmentreviews.com
  • Indicaciones y recomendaciones de uso PET-CT en planificación de tratamiento de oncología radioterápica.
    Bilbao Zulaica Pedro, Lekerika Royo Natalia, Arana-Arri Eunate, Gutiérrez-Ibarluzea Iñaki, Peña Sarnago Jose Maria, Boveda Carro Elsira.
    Proyecto de Investigación Comisionada, Diciembre 2012, Eusko Jaurlaritzaren Argitalpen Zerbitzu Nagusia ISBN: 978-84-457-3293-9
    www.osakidetza.euskadi.eus